St. Vincent Healthcare Frontier Cancer Center ( Site 0008)
Billings, Montana 59102
We've found
5 trials
at this facility
Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials